Alphagan and Effexor xr drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alphagan (brimonidine tartrate) and Effexor xr (venlafaxine hydrochloride). Common drug interactions include drug ineffective among females and gastrointestinal infection among males.

The phase IV clinical study analyzes what interactions people have when they take Alphagan and Effexor xr. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Alphagan?

Alphagan has active ingredients of brimonidine tartrate. It is often used in glaucoma. eHealthMe is studying from 9,981 Alphagan users. Check the latest studies of Alphagan.

What is Effexor xr?

Effexor xr has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 35,233 Effexor xr users. Check the latest studies of Effexor xr.



On Jul, 31, 2026

32 people who take Alphagan and Effexor xr together, and have interactions are studied.

Alphagan and Effexor xr drug interactions.

What are the common drug interactions of Alphagan and Effexor Xr, by gender? *:

female:

  1. Drug ineffective
  2. Transplant
  3. Constipation
  4. Dry mouth
  5. Dyspnoea (difficult or laboured respiration)
  6. Hypertension (high blood pressure)
  7. Insomnia (sleeplessness)
  8. Intraocular pressure increased
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Urinary tract infection

male:

  1. Gastrointestinal infection (infection of stomach and intestine)
  2. Fatigue (feeling of tiredness)
  3. Cor pulmonale chronic (long lasting enlargement of the right ventricle of the heart)
  4. Cough
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Hypertensive nephropathy (hypertensive renal disease)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  9. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  10. Renal failure chronic (long lasting kidney dysfunction)

What are the common drug interactions of Alphagan and Effexor Xr, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  2. Suicidal ideation
  3. Vitreous haemorrhage (intraocular (inside the eye) bleeding)
  4. Blindness unilateral
  5. Body temperature increased
  6. Chest pain
  7. Cough
  8. Dyspnoea (difficult or laboured respiration)
  9. Hypertension (high blood pressure)
  10. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)

50-59:

  1. Intraocular pressure increased
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Blood cholesterol increased
  4. Blood glucose increased
  5. Blood triglycerides increased
  6. Breast pain
  7. Breast tenderness
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Disease recurrence
  10. Fear

60+:

  1. Drug ineffective
  2. Gastrointestinal infection (infection of stomach and intestine)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Hypertensive nephropathy (hypertensive renal disease)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  8. Renal failure chronic (long lasting kidney dysfunction)
  9. Restless legs syndrome (a powerful urge to move your legs)
  10. Rosacea (a skin condition that causes facial redness)

What are the existing conditions these people have? *

  1. Asthma: 5 people, 15.62%
  2. Pain: 3 people, 9.38%
  3. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 6.25%
  4. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Alphagan and Effexor xr?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Alphagan and Effexor xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Alphagan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Effexor xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alphagan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Effexor xr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on brimonidine tartrate and venlafaxine hydrochloride (the active ingredients of Alphagan and Effexor xr, respectively), and Alphagan and Effexor xr (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: